Cargando…
Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal
The beginning of the 21st century has been marked by three distinct waves of zoonotic coronavirus outbreaks into the human population. The COVID-19 (coronavirus disease 2019) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and emerged as a global threat endangering...
Autores principales: | El-Hachem, Nehme, Eid, Edward, Nemer, Georges, Dbaibo, Ghassan, Abbas, Ossama, Rubeiz, Nelly, Zeineldine, Salah, Matar, Ghassan M., Bikorimana, Jean-Pierre, Shammaa, Riam, Haibe-Kains, Benjamin, Kurban, Mazen, Rafei, Moutih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571421/ https://www.ncbi.nlm.nih.gov/pubmed/33103068 http://dx.doi.org/10.1016/j.isci.2020.101697 |
Ejemplares similares
-
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress Response
por: Mardani, Fatemeh, et al.
Publicado: (2022) -
The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells
por: Salame, Natasha, et al.
Publicado: (2022) -
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2021)